UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 2.02 | Results of Operations and Financial Condition. |
On March 29, 2022, Core Scientific, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2021. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.
On March 29, 2022, the Company also released a corporate presentation reporting such results. A copy of the presentation is furnished hereto as Exhibit 99.2 and is incorporated herein by reference.
| Item 7.01 | Regulation FD Disclosure. |
The information contained in Item 2.02 is incorporated herein by reference.
The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | Press Release dated March 29, 2022. | |
| 99.2 | Company Presentation dated March 29, 2022. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Core Scientific, Inc. | ||||||
| Dated: March 29, 2022 | ||||||
| By: | /s/ Todd M. DuChene | |||||
| Name: | Todd M. DuChene | |||||
| Title: | Executive Vice President, General Counsel, Chief Compliance Officer and Secretary | |||||
Exhibit 99.1
| PRESS RELEASE www.corescientific.com |
Core Scientific Announces Full Fiscal Year 2021 Results
AUSTIN, Texas—March 29, 2022—Core Scientific, Inc. (NASDAQ: CORZ), a leader in high-performance, net carbon neutral blockchain infrastructure and software solutions, reported its consolidated financial results for the fiscal year ended December 31, 2021.
Fiscal Year 2021 Financial Highlights (Compared to Fiscal Year 2020)
| • | Total revenue increased by 803% to $544.5 million |
| • | Gross profit increased by 2,443% to $238.9 million |
| • | Net Income increased to $47.3 million |
| • | Adjusted EBITDA1 increased by 3,849% to $238.9 million |
| • | Self-mining operations increased BTC production 350% to 5,769 BTC2 |
| • | 5,296 BTC held at year end |
| • | Total hashrate of 13.5 EH/s consisting of 6.6 EH/s self-mining and 6.9 EH/s hosting |
“Our team produced strong results in 2021, highlighted by revenue of $544.5 million, net income of $47.3 million and adjusted EBITDA of $238.9 million,” said Mike Levitt, Core Scientific Chief Executive Officer. “Our total hashrate increased from less than 3.0 EH/s at year end 2020 to 13.5 EH/s at year end 2021. This market-leading growth generated over 5,700 self-mined bitcoins in 2021. In the first two months of 2022 our total hashrate grew to 15.9 EH/s and we self-mined over 2,000 bitcoins. Across our business we are executing our plans effectively and remain well positioned to continue expanding our capacity and creating shareholder value.”
FISCAL YEAR 2021 FULL YEAR FINANCIAL RESULTS
Total revenue increased by $484.2 million or 803%, to $544.5 million in 2021 from $60.3 million in 2020.
Total hosting revenue increased by $37.7 million, or 91%, to $79.3 million in 2021 from $41.6 million in 2020. The increase was driven by the execution of new customer hosting contracts for miners deployed during the year ended December 31, 2021.
Total equipment sales increased by $235.6 million, or 1,871%, to $248.2 million in 2021 from $12.6 million in 2020. The increase was driven by higher demand for new generation mining equipment.
Digital asset mining income increased by $210.8 million, or 3,440%, to $216.9 million in 2021 from $6.1 million in 2020. The year over year growth in mining income was driven by an increase in our self-mining hash rate and higher bitcoin prices. Our self-mining hash rate increased by 1,772%, to 6.6 EH/s in 2021 from 0.35 EH/s in 2020. The total number of bitcoins awarded in 2021 (excluding 1,746 of bitcoins mined by Blockcap prior to its acquisition on July 30, 2021) was 4,0233 compared to 3283 in 2020. The average price of bitcoin in 2021 was $47,437 compared to $14,357 in 2020, an improvement of 230%.
| 1 | Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP financial measures, please refer to the “Non-GAAP Financial Measures” section of this press release. |
| 2 | Includes 1,746 of bitcoin mined by Blockcap during 2021 prior to being acquired on July 30, 2021. |
| 3 | The total number of bitcoin awarded on a combined self-mining basis for December 31, 2021 was 5,769 compared to 1,281 for the year ended December 31, 2020. |
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 2
Cost of revenue increased by $254.7 million or 500%, to $305.6 million in 2021 from $50.9 million in 2020. The increase was primarily attributable to an increase in the cost of equipment sold of $166.8 million, higher power consumption driven by increases in both our self-mining and hosted fleet of $53.4 million, increased depreciation expense of $21.3 million driven by the deployment of self-mining units, facilities depreciation of $1.9 million, higher personnel and facilities operating costs driven by the opening and expansion of our data centers of $7.2 million and stock-based compensation of $4.1 million. As a percentage of total revenue, cost of revenue totaled 56% and 84% for the year ended December 31, 2021 and 2020, respectively.
Gross profit increased by $229.5 million, or 2,443%, to $238.9 million in 2021 from $9.4 million in 2020. The increase in gross profit was driven primarily by a $163.6 million increase in gross profit for the mining segment, which had a gross margin of 77% in 2021 compared to 51% in 2020. Also contributing to the increase in gross profit was a $65.9 million increase in gross profit for the Equipment Sales and Hosting Segment, which had a gross margin of 22% in 2021 compared to 12% in 2020, driven by higher margins on equipment sales.
Operating income increased $137.8 million to $131.5 million in 2021 from an operating loss of $6.3 million in 2020. The increase in operating income was predominantly due to the $229.5 million increase in gross profit described above, primarily offset by $46.0 million of higher general and administrative expenses, which was driven by $29.8 million of higher stock-based compensation expense, and $37.2 million of higher impairments of digital currency assets, which was driven by a change we made to our digital asset investment policy in the second half of 2021 to begin holding a more significant portion of our digital assets mined on our balance sheet.
Net income increased $59.5 million to $47.3 million in 2021 from a net loss of $12.2 million in 2020. The increase in net income was due to the $137.8 million increase in operating income described above, primarily offset by $41.3 million of non-operating expenses related to our convertible notes, consisting of $25.3 million of interest expense and $16.0 million of other fair value adjustments, a $14.6 million increase in interest expense from other financing arrangements, including a senior secured credit facility and several equipment financing agreements for which the proceeds were used to acquire self-mining equipment and to fund the build out of our hosting and self-mining facilities, and a $6.7 million increase in loss from debt extinguishments due to the payoff of senior secured loans in April 2021.
Adjusted EBITDA increased $232.9 million to $238.9 million in 2021 from $6.1 million in 2020. The increase was due to higher gross profit, excluding depreciation and amortization, partially offset by higher operating expenses, excluding share-based compensation and depreciation and amortization.
As of December 31, 2021, cash and cash equivalents were $117.9 million and restricted cash was $13.8 million.
As of December 31, 2021, the Company had a total Bitcoin balance of 5,296. The carrying value of our mined digital assets was $234.3 million, which reflects impairment charges of $37.2 million year-to-date.
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 3
OUTLOOK
In 2022, the Company expects to achieve total hashrate of between 40 EH/s and 42 EH/s, with total power between 1,200 MW and 1,300 MW.
The foregoing estimates are forward-looking and reflect management’s view of current and future market conditions, subject to certain risks and uncertainties and general economic and business conditions in the United States and elsewhere in the world. Investors are reminded that actual results may differ materially from these estimates.
DAILY PRODUCTION REPORTING
Core Scientific anticipates providing daily bitcoin production beginning early in April 2022 via www.corescientific.com
CONFERENCE CALL AND WEBCAST
In conjunction with this release, Core Scientific, Inc. will host a conference call today, Tuesday, March 29, 2022, at 4:30 pm Eastern Time that will be webcast live. Mike Levitt, Chief Executive Officer, Michael Trzupek, Chief Financial Officer and Steven A. Gitlin, Senior Vice President Investor Relations, will host the call.
Investors may dial into the call by using the following telephone numbers, 1 (844) 200-6205 (U.S. toll-free), 1 (646) 904-5544 (U.S. local) or 1 (929) 526-1599 (international) and providing the access code 892840 five to ten minutes prior to the start time to allow for registration.
Investors with Internet access may listen to the live audio webcast via the Investor Relations page of the Core Scientific, Inc. website, http://investors.corescientific.com. Please allow 15 minutes prior to the call to download and install any necessary audio software. A replay of the audio webcast will be available for one year.
A supplementary investor presentation for the full fiscal year 2021 can be accessed at https://investors.corescientific.com/investors/events-and-presentations/default.aspx.
AUDIO REPLAY
An audio replay of the event will be archived on the Investor Relations section of the Company’s website at http://investors.corescientific.com and via telephone by dialing 1 (866) 813-9403 (U.S. toll free), 1 (929) 458-6194 (U.S. local) or 44 (204) 525-0658 (all other locations) and entering Access Code 892840.
ABOUT CORE SCIENTIFIC
Core Scientific is one of the largest publicly traded, net carbon-neutral blockchain infrastructure providers and miners of digital assets in North America. Core Scientific has operated blockchain infrastructure in North America since 2017, using its facilities and intellectual property portfolio that has grown to more than 70 patents or applications for digital asset hosted mining and self-mining. Core Scientific operates data centers in Georgia, Kentucky, North Carolina, North Dakota and Texas, and expects to commence operations in Oklahoma in the second half of 2022. Core Scientific’s proprietary Minder® fleet management software combines the Company’s hosting expertise with data analytics to deliver maximum uptime, alerting, monitoring and management of all miners in the Company’s network. To learn more, visit www.corescientific.com.
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 4
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this press release may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our and our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example, statements about:
| • | execute its business strategy, including monetization of services provided and expansions in and into existing and new lines of business; |
| • | realize the benefits expected from the acquisition of Blockcap, including any related synergies; |
| • | anticipate the uncertainties inherent in the development of new business lines and business strategies; |
| • | retain and hire necessary employees; |
| • | anticipate the impact of the COVID-19 pandemic, including variant strains of COVID-19, and its effect on business and financial conditions; |
| • | our ability to source clean and renewable energy; |
| • | future estimates of computing capacity and operating power; |
| • | future demand for hosting capacity; |
| • | future estimates of hashrate (including mix of self-mining and hosting); |
| • | operating gigawatts and power; |
| • | future projects in construction or negotiation and future expectations of operation location; |
| • | orders for miners and critical infrastructure; |
| • | future estimates of self-mining capacity; |
| • | future infrastructure additions and their operational capacity; |
| • | operating power and site features of our operations center in Denton, Texas; |
| • | manage risks associated with operational changes in response to the COVID-19 pandemic, including the emergence of variant strains of COVID-19; |
| • | increase brand awareness; |
| • | attract, train and retain effective officers, key employees or directors; |
| • | upgrade and maintain information technology systems; |
| • | acquire and protect intellectual property; |
| • | meet future liquidity requirements and comply with restrictive covenants related to long-term indebtedness; |
| • | effectively respond to general economic and business conditions, including the price of bitcoin; |
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 5
| • | maintain the listing on, or to prevent the delisting of our securities from, Nasdaq or another national securities exchange; |
| • | obtain additional capital, including use of the debt market; |
| • | the public float of our shares; |
| • | enhance future operating and financial results; |
| • | successfully execute expansion plans; |
| • | anticipate rapid technological changes; |
| • | comply with laws and regulations applicable to its business, including tax laws and laws and regulations related to data privacy and the protection of the environment; |
| • | stay abreast of modified or new laws and regulations applicable to its business or withstand the impact of any new laws and regulations related to its industry; |
| • | anticipate the impact of, and response to, new accounting standards; |
| • | anticipate the significance and timing of contractual obligations; |
| • | maintain key strategic relationships with partners and distributors; |
| • | respond to uncertainties associated with product and service development and market acceptance; |
| • | anticipate the impact of changes in U.S. federal income tax laws, including the impact on deferred tax assets; |
| • | successfully defend litigation; and |
| • | successfully deploy the proceeds from the Business Combination. |
These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
You should read this press release with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 6
Core Scientific, Inc.
Consolidated Balance Sheets
(in thousands, except par value)
(Unaudited)
| December 31, | ||||||||
| 2021 | 2020 | |||||||
| Assets | ||||||||
| Current Assets: |
||||||||
| Cash and cash equivalents |
$ | 117,871 | $ | 8,671 | ||||
| Restricted cash |
13,807 | 50 | ||||||
| Accounts receivable, net of allowance of $— and $620, respectively |
1,382 | 792 | ||||||
| Accounts receivable from related parties |
300 | 315 | ||||||
| Deposits for equipment |
358,791 | 54,818 | ||||||
| Digital currency assets |
234,298 | 63 | ||||||
| Prepaid expenses and other current assets |
30,111 | 6,210 | ||||||
|
|
|
|
|
|||||
| Total Current Assets |
756,560 | 70,919 | ||||||
|
|
|
|
|
|||||
| Property, plant and equipment, net |
597,304 | 85,244 | ||||||
| Goodwill |
1,055,760 | 58,241 | ||||||
| Intangible assets, net |
8,195 | 6,674 | ||||||
| Other noncurrent assets |
21,045 | 4,499 | ||||||
|
|
|
|
|
|||||
| Total Assets |
$ | 2,438,864 | $ | 225,577 | ||||
|
|
|
|
|
|||||
| Liabilities, Redeemable Preferred Stock and Stockholders’ Equity | ||||||||
| Current Liabilities: |
||||||||
| Accounts payable |
$ | 11,617 | $ | 3,057 | ||||
| Accrued expenses and other |
67,862 | 3,585 | ||||||
| Deferred revenue |
63,417 | 38,113 | ||||||
| Deferred revenue from related parties |
72,945 | 6,730 | ||||||
| Capital lease obligations, current portion |
28,452 | 2,146 | ||||||
| Notes payable, current portion |
75,996 | 16,016 | ||||||
|
|
|
|
|
|||||
| Total Current Liabilities |
320,289 | 69,647 | ||||||
|
|
|
|
|
|||||
| Capital lease obligations, net of current portion |
62,145 | 2,263 | ||||||
| Notes payable, net of current portion (includes $557,007 and $— at fair value) |
652,213 | 19,864 | ||||||
| Other noncurrent liabilities |
18,531 | 103 | ||||||
|
|
|
|
|
|||||
| Total Liabilities |
1,053,178 | 91,877 | ||||||
|
|
|
|
|
|||||
| Contingently redeemable preferred stock; $0.00001 par value; 50,000 shares authorized; 6,766 shares issued and outstanding at December 31, 2021 and 2020, respectively; $45,164 total liquidation preference for both December 31, 2021 and 2020 |
44,476 | 44,476 | ||||||
| Stockholders’ Equity: |
||||||||
| Common stock; $0.00001 par value; 300,000 and 200,000 shares authorized at December 31, 2021 and 2020, respectively; 169,719 and 98,607 shares issued and outstanding at December 31, 2021 and 2020, respectively |
2 | 1 | ||||||
| Additional paid-in capital |
1,379,606 | 163,967 | ||||||
| Accumulated deficit |
(27,432 | ) | (74,744 | ) | ||||
| Accumulated other comprehensive loss |
(10,966 | ) | — | |||||
|
|
|
|
|
|||||
| Total Stockholders’ Equity |
1,341,210 | 89,224 | ||||||
|
|
|
|
|
|||||
| Total Liabilities, Redeemable Preferred Stock and Stockholders’ Equity |
$ | 2,438,864 | $ | 225,577 | ||||
|
|
|
|
|
|||||
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 7
Core Scientific, Inc.
Consolidated Statements of Operations
(in thousands, except per share amounts)
(Unaudited)
| Year Ended December 31, |
||||||||
| 2021 | 2020 | |||||||
| Revenue: |
||||||||
| Hosting revenue from customers |
$ | 62,350 | $ | 34,615 | ||||
| Hosting revenue from related parties |
16,973 | 6,983 | ||||||
| Equipment sales to customers |
138,376 | 11,193 | ||||||
| Equipment sales to related parties |
109,859 | 1,402 | ||||||
| Digital asset mining income |
216,925 | 6,127 | ||||||
|
|
|
|
|
|||||
| Total revenue |
544,483 | 60,320 | ||||||
| Cost of revenue: |
||||||||
| Cost of hosting services |
77,678 | 36,934 | ||||||
| Cost of equipment sales |
177,785 | 11,017 | ||||||
| Cost of digital asset mining |
50,158 | 2,977 | ||||||
|
|
|
|
|
|||||
| Total cost of revenue |
305,621 | 50,928 | ||||||
|
|
|
|
|
|||||
| Gross profit |
238,862 | 9,392 | ||||||
| (Loss) gain on legal settlements |
(2,636 | ) | 5,814 | |||||
| Gain from sales of digital currency assets |
4,814 | 69 | ||||||
| Impairment of digital currency assets |
(37,206 | ) | (4 | ) | ||||
| Operating expenses: |
||||||||
| Research and development |
7,674 | 5,271 | ||||||
| Sales and marketing |
4,062 | 1,771 | ||||||
| General and administrative |
60,604 | 14,556 | ||||||
|
|
|
|
|
|||||
| Total operating expenses |
72,340 | 21,598 | ||||||
|
|
|
|
|
|||||
| Operating income (loss) |
131,494 | (6,327 | ) | |||||
| Non-operating expenses, net: |
||||||||
| Loss on debt from extinguishment |
8,016 | 1,333 | ||||||
| Interest expense, net |
44,354 | 4,436 | ||||||
| Other non-operating expenses, net |
16,049 | 110 | ||||||
|
|
|
|
|
|||||
| Total non-operating expense, net |
68,419 | 5,879 | ||||||
|
|
|
|
|
|||||
| Income (loss) before income taxes |
63,075 | (12,206 | ) | |||||
| Income tax expense |
15,763 | — | ||||||
|
|
|
|
|
|||||
| Net income (loss) |
$ | 47,312 | $ | (12,206 | ) | |||
|
|
|
|
|
|||||
| Deemed dividend from common to preferred exchange |
— | (10,478 | ) | |||||
|
|
|
|
|
|||||
| Net income (loss) attributable to common stockholders |
$ | 47,312 | $ | (22,684 | ) | |||
|
|
|
|
|
|||||
| Net income (loss) per share |
||||||||
| Basic |
$ | 0.37 | $ | (0.23 | ) | |||
|
|
|
|
|
|||||
| Diluted |
$ | 0.32 | $ | (0.23 | ) | |||
|
|
|
|
|
|||||
| Weighted average shares outstanding: |
||||||||
| Basic |
129,527 | 98,492 | ||||||
|
|
|
|
|
|||||
| Diluted |
145,802 | 98,492 | ||||||
|
|
|
|
|
|||||
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 8
Core Scientific, Inc.
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
| Year Ended December 31, |
||||||||
| 2021 | 2020 | |||||||
| Cash flows from Operating Activities: |
||||||||
| Net income (loss) |
$ | 47,312 | $ | (12,206 | ) | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
| Depreciation and amortization |
33,362 | 9,403 | ||||||
| Stock-based compensation |
38,937 | 3,037 | ||||||
| Digital asset mining income |
(216,925 | ) | (6,127 | ) | ||||
| Deferred income taxes |
9,528 | — | ||||||
| Loss on legal settlements |
2,636 | — | ||||||
| Loss on debt extinguishment |
8,016 | 1,333 | ||||||
| Fair value adjustment on convertible notes |
31,217 | — | ||||||
| Amortization of debt discount and debt issuance costs |
1,374 | 1,300 | ||||||
| Losses on disposals of property, plant and equipment |
118 | 2 | ||||||
| Gain from sales of digital currency assets |
— | — | ||||||
| Impairments of digital currency assets |
37,206 | 4 | ||||||
| Provision for doubtful accounts |
— | 616 | ||||||
| Changes in working capital components: |
||||||||
| Accounts receivable, net |
(7,421 | ) | (1,303 | ) | ||||
| Accounts receivable from related parties |
16 | (243 | ) | |||||
| Digital currency assets |
24,011 | 6,090 | ||||||
| Deposits for equipment for sales to customers |
(244,399 | ) | (54,736 | ) | ||||
| Prepaid expenses and other current assets |
(34,076 | ) | (2,353 | ) | ||||
| Accounts payable |
(21,991 | ) | (1,770 | ) | ||||
| Accrued expenses and other |
56,200 | 1,625 | ||||||
| Deferred revenue |
184,340 | 30,009 | ||||||
| Other noncurrent assets and liabilities, net |
(6,196 | ) | 1,554 | |||||
|
|
|
|
|
|||||
| Net cash used in operating activities |
(56,735 | ) | (23,765 | ) | ||||
|
|
|
|
|
|||||
| Cash flows from Investing Activities: |
||||||||
| Purchases of property, plant and equipment |
(365,210 | ) | (13,668 | ) | ||||
| Cash acquired (paid) in acquisitions |
704 | (1,568 | ) | |||||
| Deposits for self-mining equipment |
(59,275 | ) | — | |||||
| Other |
(59 | ) | 92 | |||||
|
|
|
|
|
|||||
| Net cash used in investing activities |
(423,840 | ) | (15,144 | ) | ||||
|
|
|
|
|
|||||
| Cash flows from Financing Activities: |
||||||||
| Proceeds from issuances of common stock options and warrants |
513 | 2,642 | ||||||
| Issuances of debt |
670,750 | 45,178 | ||||||
| Principal payments on debt |
(57,049 | ) | (7,097 | ) | ||||
| Payment for transaction cost |
(10,682 | ) | — | |||||
|
|
|
|
|
|||||
| Net cash provided by financing activities |
603,532 | 40,723 | ||||||
|
|
|
|
|
|||||
| Increase in cash, cash equivalents, and restricted cash |
122,957 | 1,814 | ||||||
| Cash, cash equivalents and restricted cash—beginning of period |
8,721 | 6,907 | ||||||
|
|
|
|
|
|||||
| Cash, cash equivalents and restricted cash—end of period |
$ | 131,678 | $ | 8,721 | ||||
|
|
|
|
|
|||||
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 9
Core Scientific, Inc.
Segment Results
(in thousands)
(Unaudited)
| Year Ended December 31, | ||||||||
| 2021 | 2020 | |||||||
| Equipment Sales and Hosting Segment |
||||||||
| Revenue: |
||||||||
| Hosting revenue |
$ | 79,323 | $ | 41,598 | ||||
| Equipment sales |
248,235 | 12,595 | ||||||
|
|
|
|
|
|||||
| Total revenue |
327,558 | 54,193 | ||||||
| Cost of revenue: |
||||||||
| Cost of hosting services |
77,678 | 36,934 | ||||||
| Cost of equipment sales |
177,785 | 11,017 | ||||||
|
|
|
|
|
|||||
| Total Cost of revenue |
$ | 255,463 | $ | 47,951 | ||||
|
|
|
|
|
|||||
| Gross profit |
$ | 72,095 | $ | 6,242 | ||||
| Gross margin4 |
22 | % | 12 | % | ||||
| Mining Segment |
| |||||||
| Digital asset mining income |
$ | 216,925 | $ | 6,127 | ||||
|
|
|
|
|
|||||
| Total revenue |
216,925 | 6,127 | ||||||
| Cost of revenue |
50,158 | 2,977 | ||||||
|
|
|
|
|
|||||
| Gross profit |
$ | 166,767 | $ | 3,150 | ||||
| Gross margin4 |
77 | % | 51 | % | ||||
| Consolidated |
||||||||
| Consolidated total revenue |
$ | 544,483 | $ | 60,320 | ||||
| Consolidated cost of revenue |
$ | 305,621 | $ | 50,928 | ||||
| Consolidated gross profit |
$ | 238,862 | $ | 9,392 | ||||
| Consolidated gross margin4 |
44 | % | 16 | % | ||||
| 4 | Gross margin is calculated as gross profit as a percentage of total revenue. |
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 10
Core Scientific, Inc. and Subsidiaries
Non-GAAP Financial Measures
(Unaudited)
Adjusted EBITDA is a non-GAAP financial measure defined as our net income or (loss), adjusted to eliminate the effect of (i) interest income, interest expense, and other income (expense), net; (ii) provision for income taxes; (iii) depreciation and amortization; (iv) stock-based compensation expense; and (v) certain additional non-cash and non-recurring items. For additional information, including the reconciliation of net income (loss) to Adjusted EBITDA, please refer to the table below. We believe Adjusted EBITDA is an important measure because it allows management, investors, and our board of directors to evaluate and compare our operating results, including our return on capital and operating efficiencies, from period-to-period by making the adjustments described above. In addition, it provides useful information to investors and others in understanding and evaluating our results of operations, as well as provides a useful measure for period-to-period comparisons of our business, as it removes the effect of net interest expense, taxes, certain non-cash items, variable charges, and timing differences. Moreover, we have included Adjusted EBITDA in this press release because it is a key measurement used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic and financial planning.
The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature, or because the amount and timing of these items is unpredictable, not driven by core results of operations and renders comparisons with prior periods and competitors less meaningful. However, you should be aware that when evaluating Adjusted EBITDA, we may incur future expenses similar to those excluded when calculating these measures. Our presentation of this measure should not be construed as an inference that its future results will be unaffected by unusual or non-recurring items. Further, this non-GAAP financial measure should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We compensate for these limitations by relying primarily on GAAP results and using Adjusted EBITDA on a supplemental basis. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies because not all companies calculate this measure in the same fashion. You should review the reconciliation of net income (loss) to Adjusted EBITDA below and not rely on any single financial measure to evaluate our business. The following table presents a reconciliation of net income (loss) to Adjusted EBITDA for the years ended December 31, 2021 and 2020:
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 11
The following tables reconcile the Non-GAAP Financial Measures to the most directly comparable U.S. GAAP financial performance measure, which is net income (loss), for the periods presented (in thousands):
| Year Ended December 31, |
||||||||
| 2021 | 2020 | |||||||
| Net income (loss) |
$ | 47,312 | $ | (12,206 | ) | |||
|
|
|
|
|
|||||
| Adjustments: |
||||||||
| Interest expense, net |
44,354 | 4,436 | ||||||
| Income tax expense |
15,763 | — | ||||||
| Depreciation and amortization |
33,362 | 9,403 | ||||||
| Loss on debt from extinguishment |
8,016 | 1,333 | ||||||
| Stock-based compensation expense |
38,937 | 3,037 | ||||||
| Loss on legal settlements |
2,636 | — | ||||||
| Fair value adjustment on convertible notes |
16,047 | — | ||||||
| Gain from sales of digital currency assets |
(4,814 | ) | (69 | ) | ||||
| Impairment of digital currency assets |
37,206 | 4 | ||||||
| Losses on disposals of property, plant and equipment |
118 | 2 | ||||||
| Other non-cash and non-recurring items |
3 | 111 | ||||||
|
|
|
|
|
|||||
| Adjusted EBITDA |
$ | 238,940 | $ | 6,051 | ||||
|
|
|
|
|
|||||
-more-
Core Scientific, Inc. Q4 FY 2021 Earnings Release - 12
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
For additional media and information, please follow us
https://www.linkedin.com/company/corescientific/
https://twitter.com/core_scientific
CONTACTS
Investors:
Steven Gitlin
Media:
-end-
Exhibit 99.2 Fiscal Year 2021 Earnings Presentation March 29, 2022
Legal Disclaimer Forward-LookingStatements This presentation includes “forward-looking statements'' within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, those related to the Company’s ability to scale and grow its business, source clean and renewable energy, the advantages and expected growth of the Company, future estimates of revenue, net income and adjusted EBITDA, future estimates of computing capacity and operating power, future demand for hosting capacity, future estimate of hashrate (including mix of self-mining and hosting), operating gigawatts and power, future projects in construction or negotiation and future expectations of operation location, orders for miners and critical infrastructure, future estimates of self-mining capacity, the public float of the Company’s shares, future infrastructure additions and their operational capacity, and operating power and site features of the Company’s operations center in Denton, Texas. These statements are provided for illustrative purposes only and are based on various assumptions and on the current expectations of the Company’s management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including those identified in the Company’s reports filed with the U.S. Securities and Exchange Commission (”SEC”) from time to time, including the Company’s definitive proxy statement filed with the SEC on January 3, 2022, and other subsequent filings the Company files with the SEC from time to time, including its Annual Report on Form 10-K for the year ended December 31, 2021 and Current Report on Form 8-K filed on January 24, 2022. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Accordingly, undue reliance should not be placed upon the forward-looking statements. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Year over year comparisons are based on the combined results of Core Scientific and its acquired entities. Non-GAAP FinancialMeasures This presentation also contains non-GAAP financial measures as defined by the SEC rules, including Adjusted EBITDA. The Company believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company's management uses certain of these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses and for budgeting and planning purposes. The Company urges investors not to rely on any single financial measure to evaluate its business. MARCH 29, 2022 2
Fiscal Year 2021 Key Highlights • Strong financial results • Market-leading scale • Good progress toward achieving 2022 growth projections • Strong market position MARCH 29, 2022 3
Fiscal 2021 Performance Summary Metric (dollars in millions) Full Fiscal Year 2021 Notes Ending hashrate 13.5 EH/s Exceeded previous guidance by 23% 1 Bitcoins produced 5,769 Produced 1,044 bitcoins in December Bitcoins held 5,296 $224.8 million carrying value as of 12/31/21 ($42,500/1 BTC) Expanded capacity in Marble, Dalton, Calvert City and began Power 450+ MW operations in Grand Forks Revenue $544.5 Driven by overall increased operating capacity and higher Net Income $47.3 self-mining mix 2 Adjusted EBITDA $238.9 1 Proforma data based on Core Scientific and acquired entities’ bitcoin production in 2021. 2 Adjusted EBITDA is a non-GAAP financial measure. See slide 13 for a reconciliation of adjusted EBITDA to its most comparable GAAP figure. MARCH 29, 2022 4
Core Scientific Mined More Bitcoins in the Last Three Months than Other Publicly Traded Digital Asset Miners Market Leader In A Large, Growing Market 457 BTC Mined (Dec ‘21 - Feb ‘22) 350 3,102 (1) 144 105 2021 MW Online 50 30 1,319 1,307 4000 873 3,102 3500 3000 2500 BTC Mined 2000 360 1,319 1,307 1500 873 1000 (Dec 21 Feb 22) 0 361 500 NM 0 Core Scientific Riot Blockchain Marathon Hut 8 Iris Energy Terawulf Sources: (5) • RIOT: BTC mined from monthly Production and Operations press releases dated 1/5/22 , 2/4/22, 3/3/22 41 45 40 • MARA: BTC mined from monthly Production and Operations press releases dated 1/3/22, 2/4/22, 3/4/22 35 (2) • Hut8: BTC mined from monthly Production Updates dated 1/5/22, 2/3/22, 3/10/22 30 23 2022 Expected 25 • Iris Energy: BTC mined from monthly investor updates dated 1/11/22, 2/7/22, 3/8/22 (3) 20 13 • Terawulf: announced commencement of mining activities in press release dated 3/4/22 15 10 Hash Rate 7 6 10 5 (4) MARCH 29, 2022 5 (EH/s) 0 Source: Equity Research, Company Presentations. 1) Does not include capacity outsourced by third parties. 2) Marathon is expected to deploy a total of 23 EH/s by early-2023. 3) Iris Energy indicates that 10Eh/s will be deployed by early-2023 4) Hash rate includes both mining and hosting. 5) Represents midpoint of 40 EH/s to 42 EH/s per company guidance for 2022E performance. PROPRIETARY & CONFIDENTIAL 12
Expanding Our Distributed Footprint Across Multiple Geographies MARCH 29, 2022 6
Expanded Capacity and Increased Self-Mining Drove Increases in Revenue and Adjusted EBITDA Revenue, Net Income, Revenue (Millions) Adj. EBITDA (Millions) (Unaudited) 2020 2021 Equipment Sales $12.6 $248.2 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Self-Mining $6.1 $216.9 Equipment Sales $31.9 $46.0 $35.5 $134.8 Hosting $41.6 $79.3 Self-Mining $9.6 $10.8 $57.1 $139.4 Net Income $(12.2) $47.3 Hosting $12.7 $18.6 $20.5 $27.6 Adjusted EBITDA $6.1 $238.9 MARCH 29, 2022 7
Select 2021 Quarterly and Annual Results (Thousands) First Second Third Fourth Fiscal Year Fiscal Year Quarter Quarter Quarter Quarter 2021 2020 inasdf Unaudited Revenue $54,246 $75,303 $113,139 $301,795 $544,483 $60,320 Cost of Revenue $39,713 $50,766 $54,714 $160,428 $305,621 $50,928 Research and Development $1,208 $1,437 $1,586 $3,443 $7,674 $5,271 Operating Expenses $5,537 $8,996 $38,876 $18,931 $72,340 $21,598 Net Income (loss) $6,849 $(3,414) $(16,629) $60,506 $47,312 $(12,206) 1 Adjusted EBITDA $12,500 $20,770 $54,731 $150,939 $238,940 $6,051 Adjusted EBITDA Margin 23.0% 27.6% 48.4% 50.0% 43.9% 10.0% 1 Adjusted EBITDA is a non-GAAP financial measure. See slide 13 for a reconciliation of adjusted EBITDA to its most comparable GAAP figure. MARCH 29, 2022 8
Expectations For Fiscal Year 2022 Fiscal Year 2021 Fiscal Year 2022 Metric Results Expectations Hashrate 13.5 EH/s 40 to 42 EH/s Power 450+ MW 1,200 to 1,300 MW MARCH 29, 2022 9
Good Progress toward Achieving 2022 Goals Projected Year-End 2022 Hashrate (EH/s) 41 EH/s Midpoint of 4.3 Guidance Range 1 23.2 13.5 Hashrate from Miners Ordered and Hosting Year-End 2021 Contracted in 2021 to Install in 2022 Hashrate from Miners to Order and Hosting to Contract and Install in 2022 MARCH 29, 2022 10
Why Core Scientific? MARKET LEADER FULL SPECTRUM TRACK TEAM IP RECORD 1 2 4 5 3 A Leading Consistent Growth in Integrated Self- Deep, Experienced Proprietary Blockchain Capacity and Infrastructure Mining and Hosting Team Technology Capability Developer at Scale MARCH 29, 2022 11
Infrastructure to Power the World’s New Financial System 12
Appendix A – Reconciliation of Fiscal Year 2020-2021 Adjusted EBITDA (Unaudited, Thousands) Year Ended December 31, 2021 2020 Net income (loss) $ 47,312 $ (12,206) Adjustments: Interest expense, net 44,354 4,436 Income tax expense 15,763 — Depreciation and amortization 33,362 9,403 Loss on debt from extinguishment 8,016 1,333 Stock-based compensation expense 38,937 3,037 Loss on legal settlements 2,636 — Fair value adjustment on convertible notes 16,047 — Gain from sales of digital currency assets (4,814) (69) Impairment of digital currency assets 37,206 4 Losses on disposals of property, plant and equipment 118 2 Other non-cash and non-recurring items 3 111 Adjusted EBITDA $ 238,940 $ 6,051 MARCH 29, 2022 13